UTHR

564.81

0.96% -5.46

Dopo l'orario di chiusura: 564.23 -0.58 -0.10%

United Therapeutics Corp (UTHR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché UTHR Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$570.27

Aprire:

$565

Volume 24 ore:

830.76K

Relative Volume:

1.77

Capitalizzazione di mercato:

$24.75B

Reddito:

$3.18B

Utile/perdita netta:

$1.33B

Rapporto P/E:

20.24

EPS:

27.9001

Flusso di cassa netto:

$1.04B

1 W Prestazione:

+6.06%

1M Prestazione:

+9.92%

6M Prestazione:

+27.37%

1 anno Prestazione:

+80.88%

Intervallo 1D:

$551.30

$577.86

Intervallo di 1 settimana:

$520.97

$607.89

Portata 52W:

$266.98

$607.89

United Therapeutics Corp Stock (UTHR) Company Profile

Nome

United Therapeutics Corp

Settore

Healthcare (1118)

Industria

Drug Manufacturers - Specialty & Generic (84)

Telefono

(301) 608-9292

Indirizzo

1000 SPRING ST, SILVER SPRING, MD

Dipendente

1,400

Cinguettio

Prossima data di guadagno

2026-02-25

Ultimi documenti SEC

UTHR's Discussions on Twitter

Compare UTHR vs TAK, ZTS, HLN, TEVA

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
UTHR United Therapeutics Corp	564.81	24.75B	3.18B	1.33B	1.04B	27.90
TAK Takeda Pharmaceutical Co Adr	18.74	59.20B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	117.94	49.79B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.93	44.27B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	30.08	35.03B	17.41B	1.43B	1.00B	1.2182

United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-20	Iniziato	Wells Fargo	Underweight
2025-09-26	Iniziato	RBC Capital Mkts	Outperform
2025-06-02	Iniziato	Cantor Fitzgerald	Overweight
2025-04-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2025-04-21	Aggiornamento	BofA Securities	Underperform → Neutral
2024-07-11	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-02-12	Aggiornamento	Goldman	Sell → Neutral
2024-02-05	Iniziato	Leerink Partners	Outperform
2023-12-08	Iniziato	Wells Fargo	Overweight
2022-12-06	Iniziato	UBS	Buy
2022-12-05	Iniziato	Goldman	Sell
2022-10-11	Iniziato	Morgan Stanley	Overweight
2022-09-20	Reiterato	BofA Securities	Underperform
2022-09-19	Ripresa	Wedbush	Outperform
2022-02-11	Iniziato	BTIG Research	Neutral
2021-07-14	Aggiornamento	Argus	Hold → Buy
2021-04-26	Ripresa	Credit Suisse	Outperform
2021-02-01	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-09-14	Ripresa	JP Morgan	Overweight
2020-06-25	Reiterato	H.C. Wainwright	Neutral
2020-03-10	Aggiornamento	Jefferies	Hold → Buy
2020-02-27	Aggiornamento	Cowen	Market Perform → Outperform
2020-01-31	Aggiornamento	JP Morgan	Neutral → Overweight
2019-12-03	Iniziato	BofA/Merrill	Underperform
2019-08-01	Aggiornamento	Jefferies	Underperform → Hold
2019-08-01	Aggiornamento	Ladenburg Thalmann	Neutral → Buy
2019-07-01	Aggiornamento	Credit Suisse	Neutral → Outperform
2019-05-17	Aggiornamento	UBS	Sell → Neutral
2019-05-09	Aggiornamento	Credit Suisse	Underperform → Neutral
2018-10-12	Aggiornamento	Standpoint Research	Hold → Buy
2018-08-08	Downgrade	Credit Suisse	Neutral → Underperform
2018-04-03	Aggiornamento	Credit Suisse	Underperform → Neutral
2018-02-22	Reiterato	Barclays	Underweight
2018-01-18	Ripresa	Credit Suisse	Underperform
2017-12-27	Reiterato	Wedbush	Outperform
2017-04-27	Reiterato	Wedbush	Outperform
2017-03-30	Iniziato	UBS	Sell
2017-03-16	Iniziato	Credit Suisse	Underperform

Mostra tutto

United Therapeutics Corp Borsa (UTHR) Ultime notizie

Apr 04, 2026

United Therapeutics Corporation (UTHR) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 04, 2026

Element Squared LLC Acquires New Position in United Therapeutics Corporation $UTHR - MarketBeat

Apr 04, 2026

Apr 02, 2026

Will United Therapeutics (UTHR) Surpass Expectations in Its Upcoming Earnings Announcement? - bitget.com

Apr 02, 2026

United Therapeutics' Strong Competitive Edge and Robust Cash Flow Indicate a Sustainable Value Opportunity - bitget.com

Apr 02, 2026

Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,610,605.00 in Stock - MarketBeat

Apr 02, 2026

Allspring Global Investments Holdings LLC Has $52.05 Million Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat

Apr 02, 2026

UTHR Stock Price, Quote & Chart | UNITED THERAPEUTICS CORP (NASDAQ:UTHR) - ChartMill

Apr 02, 2026

Apr 01, 2026

United Therapeutics: Maintaining 'Strong Buy' On Second TETON Study Program Win (UTHR) - Seeking Alpha

Apr 01, 2026

United Therapeutics Corp at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 01, 2026

BKMC Volume Surges 38-Fold as United Therapeutics Jumps - TipRanks

Apr 01, 2026

Mar 31, 2026

United Therapeutics (UTHR) CEO sells 9,500 shares under 10b5-1 plan - Stock Titan

Mar 31, 2026

United Therapeutics (NASDAQ: UTHR) CFO exercises options and sells 10k shares - Stock Titan

Mar 31, 2026

UNITED THERAPEUTICS (UTHR) director exercises options and sells 1,300 shares under 10b5-1 plan - Stock Titan

Mar 31, 2026

UNITED THERAPEUTICS (UTHR) CEO sells 9,500 shares after option exercise - Stock Titan

Mar 31, 2026

United Therapeutics Corporation (UTHR) Stock forecasts - Yahoo Finance UK

Mar 31, 2026

Wells Fargo Raises Price Target for United Therapeutics (UTHR) t - GuruFocus

Mar 31, 2026

United Therapeutics (NASDAQ:UTHR) Price Target Raised to $660.00 at HC Wainwright - MarketBeat

Mar 31, 2026

United Therapeutics (UTHR): Analyst Greg Harrison Raises Price T - GuruFocus

Mar 31, 2026

United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo - 24/7 Wall St.

Mar 31, 2026

Retirement Systems of Alabama Has $47.39 Million Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat

Mar 31, 2026

United Therapeutics (UTHR) Moves 12.5% Higher: Will This Strength Last? - Yahoo Finance

Mar 31, 2026

Mar 30, 2026

United Therapeutics (NASDAQ: UTHR) proposed sale of 1,300 shares via option - Stock Titan

Mar 30, 2026

United Therapeutics Stock Surges Due to Positive Phase 3 Trial Results - timothysykes.com

Mar 30, 2026